Skip to Content
Home > Detail
<< Back to Results
This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
For pre-surgical patients
For post-surgical patients
In order to allow for time for central genotyping and eligibility for the ALCHEMIST treatment trial, patients must register within the following eligibility windows, depending on the adjuvant treatment approach:
Sue Stanley, RN
Thank you for your feedback!
More Events >>
Get the latest news on the health topics that matter most to you.
© 2018 Spartanburg Regional Healthcare System. All Rights Reserved.